The US SCOTUS declined to hear challenges from AstraZeneca (AZN LN), Boehringer Ingelheim, Bristol Myers Squibb (BMY), Janssen (JNJ), Novartis (NOVN SW) and Novo Nordisk (NOVOB DC) to Medicare drug price negotiations, Axios reports

Newsquawk StaffPublished On the live feed at 8 more headlines followed before this page went public
Newsquawk headlinesUTC

Iranian Military Spokesperson says "if the enemy acts foolishly again, we will open new fronts against them...with new tools and methods", ISNA reports

The UN Security Council is considering a new resolution against Iran initiated by the US and Bahrain and supported by Jordan, the UAE and Qatar, Mehr reports

The US SCOTUS declined to hear challenges from AstraZeneca (AZN LN), Boehringer Ingelheim, Bristol Myers Squibb (BMY), Janssen (JNJ), Novartis (NOVN SW) and Novo Nordisk (NOVOB DC) to Medicare drug price negotiations, Axios reports

Russian Deputy Foreign Minister Ryabkov says the risks of a direct Russia-NATO clash are increasing, TASS reports

Germany sells EUR 3.844bln vs exp. EUR 5bln 2.50% 2031 Bobl: b/c 1.32x (prev. 1.04x), average yield 2.85% (prev. 2.74%), retention 23.12% (prev. 20.9%)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • Axios says it is the latest rebuff to industry arguments that the talks with the government violate free speech protections and due process rights, among other complaints.
  • Notes that negotiated prices are expected to save patients USD 1.5bln and Medicare USD 6bln.

Related headlines

The whole workspace, free to try.

Try it free